Skip to main content
. 2021 Mar 12;60(12):5686–5696. doi: 10.1093/rheumatology/keab234

Fig. 1.


Fig. 1

Cumulative hazard of (A) knee OA and (B) knee pain consultation in β-blocker–exposed and –unexposed participants

Data restricted to the last prescription of β-blocker.